{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:01:46Z","timestamp":1770310906780,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Luzhou Municipal People's Government-Southwest Medical University Science and Technology strategic cooperation","award":["NO. 2023LZXNYDJ042"],"award-info":[{"award-number":["NO. 2023LZXNYDJ042"]}]},{"name":"Clinical Medicine Program of Southwest Medical University","award":["NO.2024LCYXZX48"],"award-info":[{"award-number":["NO.2024LCYXZX48"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-025-06690-9","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T20:47:04Z","timestamp":1767732424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A nomogram based on serum CHI3L1 for predicting IVIG nonresponse in children with Kawasaki disease"],"prefix":"10.1007","volume":"185","author":[{"given":"Jialin","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinghua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0356-537X","authenticated-orcid":false,"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-8232","authenticated-orcid":false,"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"23","key":"6690_CR1","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1161\/cir.0000000000001295","volume":"150","author":"P-N Jone","year":"2024","unstructured":"Jone P-N, Tremoulet A, Choueiter N, Dominguez SR, Harahsheh AS, Mitani Y, Zimmerman M, Lin M-T, Friedman KG (2024) Update on diagnosis and management of Kawasaki disease: a scientific statement from the American Heart Association. Circulation 150(23):e481\u2013e500. https:\/\/doi.org\/10.1161\/cir.0000000000001295","journal-title":"Circulation"},{"issue":"3","key":"6690_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1001\/jamapediatrics.2018.3307","volume":"173","author":"T Sosa","year":"2019","unstructured":"Sosa T, Brower L, Divanovic A (2019) Diagnosis and management of Kawasaki disease. JAMA Pediatr 173(3):278\u2013279. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.3307","journal-title":"JAMA Pediatr"},{"issue":"8","key":"6690_CR3","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s00431-018-3182-2","volume":"177","author":"X Li","year":"2018","unstructured":"Li X, Chen Y, Tang Y, Ding Y, Xu Q, Sun L, Qian W, Qian G, Qin L, Lv H (2018) Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases. Eur J Pediatr 177(8):1279\u20131292. https:\/\/doi.org\/10.1007\/s00431-018-3182-2","journal-title":"Eur J Pediatr"},{"issue":"2","key":"6690_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jped.2022.07.003","volume":"99","author":"JH Cai","year":"2023","unstructured":"Cai JH, Tang M, Zhang HX, Luo ED, Zhang R, Shuai SP, Liang H, Tao WJ, Wu MJ, Wen Y (2023) Therapeutic window of intravenous immunoglobulin (IVIG) and its correlation with IVIG-resistant in Kawasaki disease: a retrospective study. J Pediatr (Rio J) 99(2):161\u2013167. https:\/\/doi.org\/10.1016\/j.jped.2022.07.003","journal-title":"J Pediatr (Rio J)"},{"key":"6690_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.coph.2020.08.008","volume":"54","author":"RL Zhang","year":"2020","unstructured":"Zhang RL, Lo HH, Lei C, Ip N, Chen J, Law BY-K (2020) Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease. Curr Opin Pharmacol 54:72\u201381. https:\/\/doi.org\/10.1016\/j.coph.2020.08.008","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"6690_CR6","doi-asserted-by":"publisher","first-page":"15232","DOI":"10.1038\/s41598-024-66135-5","volume":"14","author":"L Deng","year":"2024","unstructured":"Deng L, Wang T, Duan Y, Liu B, Jiang J, Liu D, Li G (2024) Neutrophil percentage-to-albumin ratio is a potential marker of intravenous immunoglobulin resistance in Kawasaki disease. Sci Rep 14(1):15232. https:\/\/doi.org\/10.1038\/s41598-024-66135-5","journal-title":"Sci Rep"},{"key":"6690_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107037","volume":"89","author":"G Li","year":"2020","unstructured":"Li G, Wang T, Gou Y, Zeng R, Liu D, Duan Y, Liu B (2020) Value of C-reactive protein\/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease-a data from multi-institutional study in China. Int Immunopharmacol 89:107037. https:\/\/doi.org\/10.1016\/j.intimp.2020.107037","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"6690_CR8","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s00380-021-01819-w","volume":"36","author":"G Li","year":"2021","unstructured":"Li G, Xu X, Chen P, Zeng R, Liu B (2021) Prognostic value of pretreatment prognostic nutritional index in intravenous immunoglobulin-resistant Kawasaki disease. Heart Vessels 36(9):1366\u20131373. https:\/\/doi.org\/10.1007\/s00380-021-01819-w","journal-title":"Heart Vessels"},{"key":"6690_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cca.2020.05.004","volume":"507","author":"G Li","year":"2020","unstructured":"Li G, Wang T, Li J, Chen P, Jia P, Zhao J, Duan Y, Liu D, Xu X, Liu B (2020) Increased concentrations of growth differentiation factor-15 in children with Kawasaki disease. Clin Chim Acta 507:264\u2013270. https:\/\/doi.org\/10.1016\/j.cca.2020.05.004","journal-title":"Clin Chim Acta"},{"key":"6690_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110600","volume":"122","author":"Y Duan","year":"2023","unstructured":"Duan Y, Li H, Luo D, Jiang J, Liu B, Li G (2023) Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease. Int Immunopharmacol 122:110600. https:\/\/doi.org\/10.1016\/j.intimp.2023.110600","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"6690_CR11","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00296-019-04375-9","volume":"39","author":"A Nandi","year":"2019","unstructured":"Nandi A, Pal P, Basu S (2019) A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study. Rheumatol Int 39(10):1797\u20131801. https:\/\/doi.org\/10.1007\/s00296-019-04375-9","journal-title":"Rheumatol Int"},{"issue":"22","key":"6690_CR12","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/circulationaha.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113(22):2606\u20132612. https:\/\/doi.org\/10.1161\/circulationaha.105.592865","journal-title":"Circulation"},{"issue":"2","key":"6690_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","volume":"149","author":"K Egami","year":"2006","unstructured":"Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149(2):237\u2013240. https:\/\/doi.org\/10.1016\/j.jpeds.2006.03.050","journal-title":"J Pediatr"},{"issue":"2","key":"6690_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","volume":"166","author":"T Sano","year":"2007","unstructured":"Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, Kogaki S, Hara J (2007) Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166(2):131\u2013137. https:\/\/doi.org\/10.1007\/s00431-006-0223-z","journal-title":"Eur J Pediatr"},{"issue":"10","key":"6690_CR15","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.jfma.2020.12.010","volume":"120","author":"C-N Huang","year":"2021","unstructured":"Huang C-N, Wu F-F, Chang Y-M, Huang H-C, Lin M-T, Wang J-K, Wu M-H (2021) Comparison of risk scores for predicting intravenous immunoglobulin resistance in Taiwanese patients with Kawasaki disease. Taiwan Yi Xue Hui Za Zhi 120(10):1884\u20131889. https:\/\/doi.org\/10.1016\/j.jfma.2020.12.010","journal-title":"Taiwan Yi Xue Hui Za Zhi"},{"key":"6690_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jpeds.2016.12.018","volume":"184","author":"R Song","year":"2017","unstructured":"Song R, Yao W, Li X (2017) Efficacy of four scoring systems in predicting intravenous immunoglobulin resistance in children with Kawasaki disease in a children\u2019s hospital in Beijing, North China. J Pediatr 184:120\u2013124. https:\/\/doi.org\/10.1016\/j.jpeds.2016.12.018","journal-title":"J Pediatr"},{"issue":"4","key":"6690_CR17","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2024.13300","volume":"30","author":"Z Qu","year":"2024","unstructured":"Qu Z, Lu Y, Ran Y, Xu D, Guo Z, Cheng M (2024) Chitinase-3 like-protein-1: a potential predictor of cardiovascular disease. Mol Med Rep 30(4):176. https:\/\/doi.org\/10.3892\/mmr.2024.13300","journal-title":"Mol Med Rep"},{"key":"6690_CR18","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15341","volume":"11","author":"R Dong","year":"2023","unstructured":"Dong R, Li J, Jiang G, Han N, Zhang Y, Shi X (2023) Novel immune cell infiltration-related biomarkers in atherosclerosis diagnosis. PeerJ 11:e15341. https:\/\/doi.org\/10.7717\/peerj.15341","journal-title":"PeerJ"},{"issue":"6","key":"6690_CR19","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1080\/08820139.2024.2366966","volume":"53","author":"B Liang","year":"2024","unstructured":"Liang B, Zhang Y, Ke D, Yan R, Jiang M-N, Li L, Zhang L-X, Zhao X-G, Yuan G-P, Xu B (2024) Serum YKL-40 and serum Krebs von den lungen-6 as potential predictive biomarkers for rheumatoid arthritis-associated interstitial lung disease. Immunol Invest 53(6):989\u20131000. https:\/\/doi.org\/10.1080\/08820139.2024.2366966","journal-title":"Immunol Invest"},{"issue":"1","key":"6690_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4905954","volume":"2022","author":"C Fang","year":"2022","unstructured":"Fang C, Chen Z, Zhang J, Pan J, Jin X, Yang M, Huang L (2022) The value of serum YKL\u201040 and TNF\u2010\u03b1 in the diagnosis of acute ST\u2010segment elevation myocardial infarction. Cardiol Res Pract 2022(1):4905954. https:\/\/doi.org\/10.1155\/2022\/4905954","journal-title":"Cardiol Res Pract"},{"issue":"10","key":"6690_CR21","first-page":"10559","volume":"10","author":"F Chen","year":"2017","unstructured":"Chen F, An Y, Wang J (2017) CHI3L1 is correlated with childhood asthma. Int J Clin Exp Pathol 10(10):10559","journal-title":"Int J Clin Exp Pathol"},{"issue":"12","key":"6690_CR22","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.7499\/j.issn.1008-8830.2309080","volume":"25","author":"Y Cao","year":"2023","unstructured":"Cao Y, Gao S, Luo G, Zhao S-Y, Tang Y-Q, Du Z-H, Pan S-L (2023) Role and mechanisms of CHI3L1 in coronary artery lesions in a mouse model of Kawasaki disease-like vasculitis. Zhongguo Dang Dai Er Ke Za Zhi 25(12):1227\u20131233. https:\/\/doi.org\/10.7499\/j.issn.1008-8830.2309080","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"1","key":"6690_CR23","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1038\/s41598-025-91935-8","volume":"15","author":"J Zou","year":"2025","unstructured":"Zou J, He X, Li W, Duan Y, Liu B, Jiang J, Luo D, Zhao J, Li G (2025) The association of serum CHI3L1 levels with the presence of Kawasaki disease. Sci Rep 15(1):7693. https:\/\/doi.org\/10.1038\/s41598-025-91935-8","journal-title":"Sci Rep"},{"issue":"1","key":"6690_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12016-020-08783-9","volume":"59","author":"R Kumrah","year":"2020","unstructured":"Kumrah R, Vignesh P, Rawat A, Singh S (2020) Immunogenetics of Kawasaki disease. Clin Rev Allergy Immunol 59(1):122\u2013139. https:\/\/doi.org\/10.1007\/s12016-020-08783-9","journal-title":"Clin Rev Allergy Immunol"},{"issue":"17","key":"6690_CR25","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/cir.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135(17):e927\u2013e999. https:\/\/doi.org\/10.1161\/cir.0000000000000484","journal-title":"Circulation"},{"issue":"1","key":"6690_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10067-022-06344-3","volume":"42","author":"N Ahmed","year":"2023","unstructured":"Ahmed N, Pal P, Azad SM, Ghosh A, Banerjee P, Sarkar SD (2023) Risk factors in IVIG-resistant Kawasaki disease and correlation with Japanese scoring systems\u2014a study from Eastern India. Clin Rheumatol 42(1):145\u2013150. https:\/\/doi.org\/10.1007\/s10067-022-06344-3","journal-title":"Clin Rheumatol"},{"issue":"6","key":"6690_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00011-006-0076-y","volume":"55","author":"C Rathcke","year":"2006","unstructured":"Rathcke C, Vestergaard H (2006) YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res 55(6):221\u2013227. https:\/\/doi.org\/10.1007\/s00011-006-0076-y","journal-title":"Inflamm Res"},{"key":"6690_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuint.2018.12.013","volume":"124","author":"H Zhang","year":"2019","unstructured":"Zhang H, Tan J-z, Luo J, Wang W (2019) Chitinase-3-like protein 1 may be a potential biomarker in patients with drug-resistant epilepsy. Neurochem Int 124:62\u201367. https:\/\/doi.org\/10.1016\/j.neuint.2018.12.013","journal-title":"Neurochem Int"},{"issue":"4","key":"6690_CR29","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2020-0145","volume":"9","author":"S Floro","year":"2022","unstructured":"Floro S, Carandini T, Pietroboni AM, De Riz MA, Scarpini E, Galimberti D (2022) Role of chitinase 3\u2013like 1 as a biomarker in multiple sclerosis: a systematic review and meta-analysis. Neurol Neuroimmunol Neuroinflamm 9(4):e1164. https:\/\/doi.org\/10.1515\/revneuro-2020-0145","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"6690_CR30","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1128\/cdli.9.3.598-604.2002","volume":"9","author":"C \u00d8stergaard","year":"2002","unstructured":"\u00d8stergaard C, Johansen JS, Benfield T, Price PA, Lundgren JD (2002) YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin Vaccine Immunol 9(3):598\u2013604. https:\/\/doi.org\/10.1128\/cdli.9.3.598-604.2002","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"6690_CR31","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1086\/315050","volume":"180","author":"C Nordenbaek","year":"1999","unstructured":"Nordenbaek C, Johansen JS, Junker P, Borregaard N, S\u00f8rensen O, Price PA (1999) YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization. J Infect Dis 180(5):1722\u20131726. https:\/\/doi.org\/10.1086\/315050","journal-title":"J Infect Dis"},{"issue":"4","key":"6690_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/14789450.2017.1304217","volume":"14","author":"F Baldacci","year":"2017","unstructured":"Baldacci F, Lista S, Cavedo E, Bonuccelli U, Hampel H (2017) Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer\u2019s disease and other neurodegenerative diseases. Expert Rev Proteomics 14(4):285\u2013299. https:\/\/doi.org\/10.1080\/14789450.2017.1304217","journal-title":"Expert Rev Proteomics"},{"issue":"8","key":"6690_CR33","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.transproceed.2014.09.017","volume":"46","author":"J Malyszko","year":"2014","unstructured":"Malyszko J, Koc-Zorawska E, Malyszko J (2014) YKL-40, a marker of cardiovascular disease and endothelial dysfunction, in kidney transplant recipients. Transplant Proc 46(8):2651\u20132653. https:\/\/doi.org\/10.1016\/j.transproceed.2014.09.017","journal-title":"Transplant Proc"},{"issue":"3","key":"6690_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5551\/jat.26385","volume":"22","author":"I Kocyigit","year":"2015","unstructured":"Kocyigit I, Gungor O, Dogan E, Karadavut S, Karakukcu C, Eroglu E, Orscelik O, Unal A, Dogan A, Sipahioglu MH (2015) The serum YKL-40 level is associated with vascular injury and predicts proteinuria in nephrotic syndrome patients. J Atheroscler Thromb 22(3):257\u2013264. https:\/\/doi.org\/10.5551\/jat.26385","journal-title":"J Atheroscler Thromb"},{"issue":"12","key":"6690_CR35","doi-asserted-by":"publisher","first-page":"22421","DOI":"10.3390\/ijms151222421","volume":"15","author":"S Wu","year":"2014","unstructured":"Wu S, Hsu L-A, Cheng S-T, Teng M-S, Yeh C-H, Sun Y-C, Huang H-L, Ko Y-L (2014) Circulating YKL-40 level, but not CHI3L1 gene variants, is associated with atherosclerosis-related quantitative traits and the risk of peripheral artery disease. Int J Mol Sci 15(12):22421\u201322437. https:\/\/doi.org\/10.3390\/ijms151222421","journal-title":"Int J Mol Sci"},{"issue":"11","key":"6690_CR36","doi-asserted-by":"publisher","first-page":"644","DOI":"10.20452\/pamw.4345","volume":"128","author":"K Sciborski","year":"2018","unstructured":"Sciborski K, Kuliczkowski W, Karolko B, Bednarczyk D, Protasiewicz M, Mysiak A, Negrusz-Kawecka M (2018) Plasma YKL-40 levels correlate with the severity of coronary atherosclerosis assessed with the SYNTAX score. Pol Arch Intern Med 128(11):644\u2013648. https:\/\/doi.org\/10.20452\/pamw.4345","journal-title":"Pol Arch Intern Med"},{"issue":"3","key":"6690_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/jcla.21500","volume":"26","author":"SH Lee","year":"2012","unstructured":"Lee SH, Lin CY, Wang PH, Han CP, Yang SF, Chang JT, Lee MC, Lin LY, Lee MS (2012) Significant association of elevated concentration of plasma YKL-40 with disease severity in patients with pelvic inflammatory disease. J Clin Lab Anal 26(3):136\u2013142. https:\/\/doi.org\/10.1002\/jcla.21500","journal-title":"J Clin Lab Anal"},{"issue":"34","key":"6690_CR38","doi-asserted-by":"publisher","first-page":"25803","DOI":"10.1016\/s0021-9258(19)74461-5","volume":"268","author":"BE Hakala","year":"1993","unstructured":"Hakala BE, White C, Recklies A (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268(34):25803\u201325810. https:\/\/doi.org\/10.1016\/s0021-9258(19)74461-5","journal-title":"J Biol Chem"},{"issue":"3","key":"6690_CR39","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/clinchem\/44.3.509","volume":"44","author":"S Harvey","year":"1998","unstructured":"Harvey S, Weisman M, O\u2019Dell J, Scott T, Visor MKJ, Swindlehurst C (1998) Chondrex: new marker of joint disease. Clin Chem 44(3):509\u2013516. https:\/\/doi.org\/10.1093\/clinchem\/44.3.509","journal-title":"Clin Chem"},{"key":"6690_CR40","doi-asserted-by":"publisher","first-page":"1582638","DOI":"10.3389\/fimmu.2025.1582638","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu Y, Huang H, Li X, Sun L, Haitao L (2025) Kawasaki disease: insights into the roles of T cells. Front Immunol 16:1582638. https:\/\/doi.org\/10.3389\/fimmu.2025.1582638","journal-title":"Front Immunol"},{"issue":"1","key":"6690_CR41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12969-025-01160-w","volume":"23","author":"L Li","year":"2025","unstructured":"Li L, Xu X, Guo Y, Yan Y, Li M, Zhao H, Wang M, Kong Q, Zhao C (2025) C-reactive protein to high density lipoprotein cholesterol ratio for predicting coronary artery lesions, and intravenous immunoglobulin resistance in Kawasaki disease. Pediatr Rheumatol Online J 23(1):108. https:\/\/doi.org\/10.1186\/s12969-025-01160-w","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"6690_CR42","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/07853890.2022.2031273","volume":"54","author":"H Huang","year":"2022","unstructured":"Huang H, Jiang J, Shi X, Qin J, Dong J, Xu L, Huang C, Liu Y, Zheng Y, Hou M (2022) Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China. Ann Med 54(1):442\u2013453. https:\/\/doi.org\/10.1080\/07853890.2022.2031273","journal-title":"Ann Med"},{"issue":"4","key":"6690_CR43","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s41390-023-02931-5","volume":"95","author":"D Xu","year":"2024","unstructured":"Xu D, Chen Y-S, Feng C-H, Cao A-M, Li X-H (2024) Development of a prediction model for progression of coronary artery lesions in Kawasaki disease. Pediatr Res 95(4):1041\u20131050. https:\/\/doi.org\/10.1038\/s41390-023-02931-5","journal-title":"Pediatr Res"},{"issue":"4","key":"6690_CR44","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16(4):e173\u2013e180. https:\/\/doi.org\/10.1016\/S1470-2045(14)71116-7","journal-title":"Lancet Oncol"},{"issue":"1","key":"6690_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sim.4085","volume":"30","author":"MJ Pencina","year":"2011","unstructured":"Pencina MJ, D\u2019Agostino SRB, Steyerberg EW (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30(1):11\u201321. https:\/\/doi.org\/10.1002\/sim.4085","journal-title":"Stat Med"},{"issue":"14","key":"6690_CR46","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1002\/sim.5647","volume":"32","author":"H Uno","year":"2013","unstructured":"Uno H, Tian L, Cai T, Kohane IS, Wei L (2013) A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med 32(14):2430\u20132442. https:\/\/doi.org\/10.1002\/sim.5647","journal-title":"Stat Med"},{"key":"6690_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1211790","volume":"14","author":"R Yu","year":"2023","unstructured":"Yu R, Liu X, Deng X, Li S, Wang Y, Zhang Y, Ke D, Yan R, Wang Q, Tian X (2023) Serum CHI3L1 as a biomarker of interstitial lung disease in rheumatoid arthritis. Front Immunol 14:1211790. https:\/\/doi.org\/10.3389\/fimmu.2023.1211790","journal-title":"Front Immunol"},{"issue":"3","key":"6690_CR48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/1744666x.2017.1232165","volume":"13","author":"S Agarwal","year":"2017","unstructured":"Agarwal S, Agrawal DK (2017) Kawasaki disease: etiopathogenesis and novel treatment strategies. Expert Rev Clin Immunol 13(3):247\u2013258. https:\/\/doi.org\/10.1080\/1744666x.2017.1232165","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"6690_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-023-01131-9","volume":"56","author":"JE Yu","year":"2024","unstructured":"Yu JE, Yeo IJ, Han S-B, Yun J, Kim B, Yong YJ, Lim Y-s, Kim TH, Son DJ, Hong JT (2024) Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer. Exp Mol Med 56(1):1\u201318. https:\/\/doi.org\/10.1038\/s12276-023-01131-9","journal-title":"Exp Mol Med"},{"key":"6690_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110680","volume":"131","author":"S Wang","year":"2020","unstructured":"Wang S, Hu M, Qian Y, Jiang Z, Shen L, Fu L, Hu Y (2020) CHI3L1 in the pathophysiology and diagnosis of liver diseases. Biomed Pharmacother 131:110680. https:\/\/doi.org\/10.1016\/j.biopha.2020.110680","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"6690_CR51","doi-asserted-by":"publisher","DOI":"10.11613\/bm.2024.010502","volume":"34","author":"N Blazevic","year":"2024","unstructured":"Blazevic N, Rogic D, Pelajic S, Miler M, Glavcic G, Ratkajec V, Vrkljan N, Bakula D, Hrabar D, Pavic T (2024) YKL-40 as a biomarker in various inflammatory diseases: a review. Biochem Med (Zagreb) 34(1):010502. https:\/\/doi.org\/10.11613\/bm.2024.010502","journal-title":"Biochem Med (Zagreb)"},{"issue":"4","key":"6690_CR52","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/SHK.0b013e31819e2c0c","volume":"32","author":"N Hattori","year":"2009","unstructured":"Hattori N, Oda S, Sadahiro T, Nakamura M, Abe R, Shinozaki K, Nomura F, Tomonaga T, Matsushita K, Kodera Y (2009) YKL-40 identified by proteomic analysis as a biomarker of sepsis. Shock 32(4):393\u2013400. https:\/\/doi.org\/10.1097\/SHK.0b013e31819e2c0c","journal-title":"Shock"},{"issue":"5","key":"6690_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/children10050772","volume":"10","author":"E Steletou","year":"2023","unstructured":"Steletou E, Metallinou D, Margeli A, Giannouchos T, Michos A, Kanaka-Gantenbein C, Papassotiriou I, Siahanidou T (2023) Serum YKL-40 as a potential biomarker for sepsis in term neonates\u2014a pilot study. Children 10(5):772. https:\/\/doi.org\/10.3390\/children10050772","journal-title":"Children"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06690-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06690-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06690-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T02:31:31Z","timestamp":1770258691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06690-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["6690"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06690-9","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of The Affiliated Hospital of Southwest Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants (parents or legal guardians) included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}